Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial
Circulation · 2026
DOI: 10.1161/circulationaha.125.075388 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Circulation, 2026. Verfasst von Sergio Raposeiras-Roubín und 34 weiteren Autor:innen. Beteiligte Einrichtung: Cardiology Department, University Hospital Álvaro Cunqueiro and Instituto de Investigación Sanitaria Galicia Sur, Vigo, Spain (S.R.R., P.D.E., A.A. A…. Hauptthemen laut MEDLINE: Acute Coronary Syndrome, Ezetimibe, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Fatty Acids. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Current guidelines recommend a stepwise strategy to achieve low-density lipoprotein cholesterol (LDL-C) goals after acute coronary syndrome (ACS). Earlier intensive strategies based on a combination of lipid-lowering therapies (LLTs) could be useful from the onset of ACS. However, the role of bempedoic acid in ACS, particularly when combined with high-intensity statins and ezetimibe, remains uncertain. The aim of ES-BempedACS (Efficacy and Security of Bempedoic Acid in Acute Coronary Syndrome) was to compare the efficacy and safety of triple LLT (high-dose, high-intensity statin+ezetimibe+bempedoic acid) versus standard of care (high-dose, high-intensity statin+ezetimibe) after ACS. METHODS: ES-BempedACS is a multicenter, independent, pragmatic, prospective, randomized, open, blinded end point controlled trial conducted in 12 Spanish hospitals between November 2023 and October 2024. The primary end point was the proportion of patients achieving LDL-C
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiology Department, University Hospital Álvaro Cunqueiro and Instituto de Investigación Sanitaria Galicia Sur, Vigo, Spain (S.R.R., P.D.E., A.A. Abejón, A.I.R.).
- University of Santiago de Compostela, Spain (S.R.R.).
- Povisa Hospital, Vigo, Spain (E.A.A.).
- Cardiology Department, University Hospital Puerta del Mar, Cádiz, Spain (C.J.M., A.V.R., M.T.G.G., J.A.P.d.l.M.).
- Cardiology Department, University Hospital of Albacete, Spain (E.M.d.l.G., M.L.V., F.S.M., M.C.-P.).
- Cardiology Department, University Hospital of Burgos, Spain (J.Á.P.R., L.A.I., A.M.M., E.S.C., I.S.S.).
ORCID-Profile: Sergio Raposeiras-Roubín, Ester Mínguez de la Guía, José Ángel Pérez Rivera, Marta Marcos Mangas, Aitor Uribarri, Pablo Jorge Pérez, Pablo José Antúnez Muinos, Ana Viana-Tejedor, Pablo Domínguez Erquicia, Lara Aguilar Iglesias, Alberto Alén Andrémar, Maria Vidal Burdeus, María Cristina González Cambeiro, Daznia Bompart, Juan Carlos Gómez Polo, Ana Merino Merino, José Rozado, Francisco Salmerón Martínez, Isabel Santos Sánchez, Ángel Víctor Hernández-Martos, Andrés Antelo Abejón, Andrés Iñiguez Romo, Miguel Corbi-Pascual
Zitieren
APA
Raposeiras-Roubín, S., Abu Assi, E., Jiménez Méndez, C., Mínguez de la Guía, E., Pérez Rivera, J. Á., Marcos Mangas, M., Ayesta, A., Uribarri, A., Jorge Pérez, P., Antúnez Muinos, P. J., Bonanad Lozano, C., Carrasquer, A., Viana-Tejedor, A., Domínguez Erquicia, P., Villar Ruiz, A., López Vázquez, M., Aguilar Iglesias, L., Alén Andrémar, A., Vidal Burdeus, M., …, & Ariza-Solé, A. (2026). Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial. Circulation. https://doi.org/10.1161/circulationaha.125.075388
Vancouver
Raposeiras-Roubín S, Abu Assi E, Jiménez Méndez C, Mínguez de la Guía E, Pérez Rivera JÁ, Marcos Mangas M, et al. Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial. Circulation. 2026. doi:10.1161/circulationaha.125.075388
BibTeX
@article{RaposeirasRoubn2026,
author = {Raposeiras-Roubín, Sergio and Abu Assi, Emad and Jiménez Méndez, César and Mínguez de la Guía, Ester and Pérez Rivera, José Ángel and Marcos Mangas, Marta and Ayesta, Ana and Uribarri, Aitor and Jorge Pérez, Pablo and Antúnez Muinos, Pablo José and Bonanad Lozano, Clara and Carrasquer, Anna and Viana-Tejedor, Ana and Domínguez Erquicia, Pablo and Villar Ruiz, Alberto and López Vázquez, Macarena and Aguilar Iglesias, Lara and Alén Andrémar, Alberto and Vidal Burdeus, Maria and Martin Cabeza, Marta Maria and González Cambeiro, María Cristina and Bompart, Daznia and Gómez Polo, Juan Carlos and García García, Marina Teresa and Merino Merino, Ana and Rozado, José and Panera de la Mano, José Antonio and Salmerón Martínez, Francisco and Sánchez Corral, Ester and Santos Sánchez, Isabel and Hernández-Martos, Ángel Víctor and Antelo Abejón, Andrés and Iñiguez Romo, Andrés and Corbi-Pascual, Miguel and Ariza-Solé, Albert},
title = {Triple Versus Dual Lipid-Lowering Therapy in Acute Coronary Syndrome: The ES-BempedACS Randomized Clinical Trial},
journal = {Circulation},
year = {2026},
doi = {10.1161/circulationaha.125.075388}
}
EUVIMED